Cahaba Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Cahaba Wealth Management's ABBV Position: Q2 2026 in Review
Cahaba Wealth Management increased its AbbVie (ABBV) stake by 1% in Q2 2026, buying an estimated $7.96K and bringing the position to 3,654 shares worth $919K. The position accounts for 0.06% of the portfolio, ranked #66.
Cahaba Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Cahaba Wealth Management held 3,654 shares of AbbVie worth $919K as of Q2 2026.
- Cahaba Wealth Management bought 37 AbbVie shares in Q2 2026, an estimated $7.96K.
- AbbVie made up 0.06% of Cahaba Wealth Management's portfolio in Q2 2026, its #66 holding.
- Cahaba Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Cahaba Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.